Blue Shield of CA's Bold Move to Bypass PBMs
Send us a text It’s no secret that medical drug prices have been out of control for most Americans. However, one hospital group has a novel idea to control drug spending. Blue Shield of California is bypassing PBMs by negotiating directly with the manufacturer of a biosimilar for Humira. Is this a one-off experiment or the start of a bigger trend that can drive industry-wide impact? In this episode of CareTalk, David E. Williams and John Driscoll discuss these price negotiation tactics an...